Publications

June 28, 2022

PVRIG and TIGIT immune checkpoint blockade in cancer: Emerging translational data from clinical trials

Pierre Ferré, AIS 2022 Montpellier, France, 28 June 2022

December 9, 2021

Harnessing PVRIG & TIGIT Combination in Anti-Cancer Immunity

Eran Ophir, VP Research & Drug Discovery, TIGIT Therapies Digital Summit

June 29, 2021

The TIGIT Pathway, PVRIG, a Novel Pathway Member, Targets for Cancer Immunotherapy: A Deep Dive

Eran Ophir, VP Research and Drug Discover June 2021.

Scroll to Top